Index

MIPS - Quality Measures

Advancing Care Information Measures
Improvement Activities Measures

;

Measure ID Title eMeasure ID Measure Type NQF ID High Priority Submission Methods Risk Adjusted? Registry Measure?
ACPGR3 Fixed-dose Combination of Hydralazine and Isosorbide Dinitrate Therapy for Self-identified Black or African American Patients with Heart Failure and LVEF <40% on ACEI or ARB and Beta-blocker Therapy Process
ACR7 Gout: Serum Urate Target Process
ACRad1 CT Colonography True Positive Rate Outcome
ACRad15 Report Turnaround Time: Radiography (modified) (Inverse Measure) Outcome
ACRad16 Report Turnaround Time: Ultrasound (Excluding Breast US) (Inverse Measure) Outcome
ACRad17 Report Turnaround Time: MRI (Inverse Measure) Outcome
ACRad18 Report Turnaround Time: CT (Inverse Measure) Outcome
ACRad19 Report Turnaround Time: PET (Inverse Measure) Outcome
ACRad2 CT Colonography Clinically Significant Extracolonic Findings (Inverse Measure) Outcome
ACRad21 Lung Cancer Screening Cancer Detection Rate (CDR) Outcome
ACRad22 Lung Cancer Screening Positive Predictive Value (PPV) Outcome
ACRad23 Lung Cancer Screening Abnormal Interpretation Rate Outcome

Page 8 of 75